
Clutter clearing speaker/author turned two-time cancer survivor shares her holiday tips.

Clutter clearing speaker/author turned two-time cancer survivor shares her holiday tips.

Holidays can be challenging, but here are a few helpful tips to surviving well.

In a word, everything.

There is no doubt the Affordable Care Act needs tweaking. But let's not lose these critical pieces.

Genetics testing may help providers know which patients with breast cancer are at higher risk for venous thromboembolism (VTE).

A diagnosis of metastatic breast cancer can be frightening, but education and new treatments are helping these patients adjust to their "new normal."

Breast cancer patients with weakened immune systems need to be protected, especially during flu season.

Many female survivors of cancer face sexual pain after treatment, and may not feel comfortable starting a conversation with their health care providers.

A six-year breast cancer survivor and three-year melanoma survivor reflects back and offers hope.

The FDA granted ribociclib a priority review to a new drug application for certain patients with breast cancer.

A new online tool can help patients with lymphedema through short exercise videos.

Sometimes you can find comfort and a little bit of relief in an irrational (and a bit silly) behavior.

Breast cancer is filled with surprises and unexpected challenges.

A new online tool will help patients with cancer engage in clearer, more meaningful conversations with their care providers.

Breast cancer and melanoma survivor finds herself waiting for results again.

Vitamin D plays an important role in helping fight breast cancer.

The party is over. Now what?

Mache Seibel discusses the benefits of taking estrogen supplements for women who harbor the BRCA genetic mutation.

For many patients with early-stage breast cancer, these drugs provide a significant boost to disease-free survival.

Laura Yeager talks about her journey with breast cancer, from the fearful thoughts to the free food at chemotherapy.

Extending hormonal therapy to 10 years has been found to reduce recurrence in HR-positive breast cancer.

In some cases, genomic blood analysis may be effective enough to replace cancer biopsies.

Do I want to be asked how I am doing? A six year breast cancer and three-year melanoma survivor ponders this question.

Herceptin has improved survival for women with HER2-positive breast cancer. Now, scientists are exploring ways to mitigate the heart problems the drug can cause.

Excitement is growing over new strategies for treating or avoiding peripheral neuropathy in patients with cancer.